Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial
Muhammad Amjad Pervez, Dilshad Ahmed Khan, Atiq Ur Rehman Slehria, Aamir Ijaz
Topics & Concepts
MedicineSteatosisInternal medicineNonalcoholic fatty liver diseaseGastroenterologyPlaceboAlanine transaminaseAspartate transaminaseLiver injuryElevated transaminasesFatty liverPathologyDiseaseBiochemistryAlkaline phosphataseEnzymeAlternative medicineChemistryLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationAntioxidant Activity and Oxidative Stress